Total Payments
$87,325
2024 Payments
$146.52
Companies
8
Transactions
78
Medicare Patients
1,327
Medicare Billing
$372,890
Payment Breakdown by Category
Other$65,536 (75.0%)
Consulting$11,402 (13.1%)
Travel$8,172 (9.4%)
Food & Beverage$1,975 (2.3%)
Education$239.97 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $65,536 | 16 | 75.0% |
| Consulting Fee | $11,402 | 11 | 13.1% |
| Travel and Lodging | $8,172 | 24 | 9.4% |
| Food and Beverage | $1,975 | 24 | 2.3% |
| Education | $239.97 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $81,055 | 63 | $0 (2022) |
| Celgene Corporation | $5,878 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $139.98 | 2 | $0 (2024) |
| Incyte Corporation | $99.99 | 1 | $0 (2022) |
| Jazz Pharmaceuticals Inc. | $95.85 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $24.48 | 1 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $20.36 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $11.60 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $146.52 | 4 | Janssen Biotech, Inc. ($74.99) |
| 2022 | $717.32 | 4 | Celgene Corporation ($317.33) |
| 2021 | $64.99 | 1 | Janssen Biotech, Inc. ($64.99) |
| 2020 | $95.85 | 1 | Jazz Pharmaceuticals Inc. ($95.85) |
| 2019 | $25,940 | 18 | E.R. Squibb & Sons, L.L.C. ($20,407) |
| 2017 | $60,360 | 50 | E.R. Squibb & Sons, L.L.C. ($60,348) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Education | In-kind items and services | $74.99 | General |
| Category: Oncology | ||||||
| 10/31/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $26.69 | General |
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Oncology | ||||||
| 10/05/2022 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $17.33 | General |
| Category: Hematology | ||||||
| 05/04/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 05/04/2022 | Celgene Corporation | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 04/13/2022 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.99 | General |
| 01/07/2021 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $64.99 | General |
| Category: Oncology | ||||||
| 01/16/2020 | Jazz Pharmaceuticals Inc. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $95.85 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/09/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,310.00 | General |
| Category: Oncology | ||||||
| 10/09/2019 | Celgene Corporation | Inrebic (Drug) | Travel and Lodging | Cash or cash equivalent | $38.00 | General |
| Category: Myelofibrosis | ||||||
| 10/04/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Travel and Lodging | Cash or cash equivalent | $252.88 | General |
| Category: Oncology | ||||||
| 10/02/2019 | Celgene Corporation | Inrebic (Drug) | Consulting Fee | Cash or cash equivalent | $2,394.00 | General |
| Category: Myelofibrosis | ||||||
| 09/27/2019 | Celgene Corporation | Inrebic (Drug) | Food and Beverage | In-kind items and services | $109.37 | General |
| Category: Myelofibrosis | ||||||
| 09/24/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $100.00 | General |
| Category: Oncology | ||||||
| 04/22/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,505.00 | General |
| Category: Oncology | ||||||
| 04/16/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Travel and Lodging | Cash or cash equivalent | $535.05 | General |
| Category: Oncology | ||||||
| 04/16/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $108.46 | General |
| Category: Oncology | ||||||
| 03/26/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Travel and Lodging | Cash or cash equivalent | $163.56 | General |
| Category: Oncology | ||||||
| 03/18/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,505.00 | General |
| Category: Oncology | ||||||
| 03/13/2019 | Celgene Corporation | Luspatercept (Drug) | Consulting Fee | Cash or cash equivalent | $2,907.50 | General |
| 02/23/2019 | Celgene Corporation | Luspatercept (Drug) | Food and Beverage | In-kind items and services | $85.00 | General |
| 02/12/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $88.91 | General |
| Category: Oncology | ||||||
| 02/06/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,310.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 391 | 891 | $321,629 | $99,847 |
| 2022 | 7 | 363 | 858 | $249,648 | $92,786 |
| 2021 | 8 | 322 | 881 | $254,254 | $97,976 |
| 2020 | 7 | 251 | 855 | $275,986 | $82,281 |
Total Patients
1,327
Total Services
3,485
Medicare Billing
$372,890
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 164 | 427 | $167,076 | $51,002 | 30.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 225 | $62,977 | $23,611 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 115 | 163 | $49,449 | $13,445 | 27.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 54 | $29,465 | $8,232 | 27.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 22 | 22 | $12,662 | $3,557 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 147 | 421 | $135,499 | $51,737 | 38.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 48 | 241 | $58,949 | $21,701 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 74 | 101 | $24,063 | $8,534 | 35.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 32 | 32 | $14,750 | $4,929 | 33.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 27 | 27 | $8,476 | $3,188 | 37.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 20 | 21 | $4,827 | $1,816 | 37.6% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2022 | 15 | 15 | $3,084 | $879.79 | 28.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 119 | 435 | $141,881 | $54,971 | 38.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 53 | 262 | $64,085 | $24,669 | 38.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 42 | 60 | $14,281 | $5,456 | 38.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 23 | 23 | $10,601 | $3,907 | 36.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 27 | 35 | $8,046 | $3,221 | 40.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 19 | 22 | $6,906 | $2,779 | 40.2% |
| 38222 | Diagnostic aspirations and biopsies of bone marrow | Facility | 2021 | 26 | 27 | $5,550 | $1,865 | 33.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 17 | $2,903 | $1,108 | 38.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 94 | 427 | $162,250 | $41,384 | 25.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 50 | 295 | $72,157 | $27,981 | 38.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 26 | 26 | $13,905 | $3,549 | 25.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 21 | 21 | $6,593 | $2,712 | 41.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 21 | 38 | $10,559 | $2,579 | 24.4% |
About Dr. Khaled El-Shami, MD
Dr. Khaled El-Shami, MD is a Medical Oncology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639225204.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khaled El-Shami, MD has received a total of $87,325 in payments from pharmaceutical and medical device companies, with $146.52 received in 2024. These payments were reported across 78 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($65,536).
As a Medicare-enrolled provider, El-Shami has provided services to 1,327 Medicare beneficiaries, totaling 3,485 services with total Medicare billing of $372,890. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Location Washington, DC
- Active Since 01/26/2007
- Last Updated 08/20/2021
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1639225204
Products in Payments
- EMPLICITI (Biological) $60,361
- OPDIVO (Biological) $20,394
- Luspatercept (Drug) $2,993
- Inrebic (Drug) $2,541
- VYXEOS (Drug) $95.85
- DARZALEX (Biological) $74.99
- IMBRUVICA (Drug) $64.99
- CALQUENCE (Drug) $24.48
- REZUROCK (Drug) $20.36
- Pomalyst (Drug) $17.33
- KEYTRUDA (Biological) $11.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Washington
Dr. Nancy Dawson, M.d, M.D
Medical Oncology — Payments: $2.1M
Medical Oncology $2.1M
Dr. Pashna Munshi, M.d, M.D
Medical Oncology — Payments: $181,342
Medical Oncology $181,342
Dr. Mitchell Smith, M.d, M.D
Medical Oncology — Payments: $66,826
Medical Oncology $66,826
Dr. Channing Paller, M.d, M.D
Medical Oncology — Payments: $35,482
Medical Oncology $35,482
Maria Nunes, Md, MD
Medical Oncology — Payments: $26,005
Medical Oncology $26,005
Giampaolo Talamo, Md, MD
Medical Oncology — Payments: $18,208
Medical Oncology $18,208